Reuters logo
BRIEF-Dawnrays Pharmaceutical says HY revenue was up 17.4 percent
August 22, 2017 / 4:17 AM / a month ago

BRIEF-Dawnrays Pharmaceutical says HY revenue was up 17.4 percent

Aug 22 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd :

* Declares an interim dividend of HK$0.03 per share for year ending 31 December 2017

* HY profit for the period attributable to owners of the parent RMB149mln, up 13.3 percent

* HY revenue RMB491.1 million, up 17.4 percent Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below